Show simple item record

dc.contributor.authorMsellem, Mwinyi I
dc.contributor.authorMårtensson, Andreas
dc.contributor.authorRotllant, Guida
dc.contributor.authorBhattarai, Achuyt
dc.contributor.authorStrömberg, Johan
dc.contributor.authorKahigwa, Elizeus
dc.contributor.authorGarcia, Montse
dc.contributor.authorPetzold, Max
dc.contributor.authorOlumese, Peter
dc.contributor.authorAli, Abdullah
dc.contributor.authorBjörkman, Anders
dc.date.accessioned2010-10-29T15:20:40Z
dc.date.available2010-10-29T15:20:40Z
dc.date.issued2009-04-28
dc.date.submitted2010-10-15
dc.identifier.citationPLoS Med. 2009;6(4):e1000070en
dc.identifier.issn1549-1676
dc.identifier.pmid19399156
dc.identifier.doi10.1371/journal.pmed.1000070
dc.identifier.urihttp://hdl.handle.net/10144/114022
dc.description.abstractBACKGROUND: The use of rapid diagnostic tests (RDTs) for Plasmodium falciparum malaria is being suggested to improve diagnostic efficiency in peripheral health care settings in Africa. Such improved diagnostics are critical to minimize overuse and thereby delay development of resistance to artemisinin-based combination therapies (ACTs). Our objective was to study the influence of RDT-aided malaria diagnosis on drug prescriptions, health outcomes, and costs in primary health care settings. METHODS AND FINDINGS: We conducted a cross-over validation clinical trial in four primary health care units in Zanzibar. Patients of all ages with reported fever in the previous 48 hours were eligible and allocated alternate weeks to RDT-aided malaria diagnosis or symptom-based clinical diagnosis (CD) alone. Follow-up was 14 days. ACT was to be prescribed to patients diagnosed with malaria in both groups. Statistical analyses with multilevel modelling were performed. A total of 1,887 patients were enrolled February through August 2005. RDT was associated with lower prescription rates of antimalarial treatment than CD alone, 361/1005 (36%) compared with 752/882 (85%) (odds ratio [OR] 0.04, 95% confidence interval [CI] 0.03-0.05, p<0.001). Prescriptions of antibiotics were higher after RDT than CD alone, i.e., 372/1005 (37%) and 235/882 (27%) (OR 1.8, 95%CI 1.5-2.2, p<0.001), respectively. Reattendance due to perceived unsuccessful clinical cure was lower after RDT 25/1005 (2.5%), than CD alone 43/882 (4.9%) (OR 0.5, 95% CI 0.3-0.9, p = 0.005). Total average cost per patient was similar: USD 2.47 and 2.37 after RDT and CD alone, respectively. CONCLUSIONS: RDTs resulted in improved adequate treatment and health outcomes without increased cost per patient. RDTs may represent a tool for improved management of patients with fever in peripheral health care settings. TRIAL REGISTRATION: (Clinicaltrials.gov) NCT00549003.
dc.language.isoenen
dc.relation.urlhttp://dx.plos.org/10.1371/journal.pmed.1000070en
dc.rightsPublished by Public Library of Science, [url]http://medicine.plosjournals.org/[/url] Archived on this site by Open Access permissionen
dc.subject.meshAdulten
dc.subject.meshAntimalarialsen
dc.subject.meshArtemisininsen
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshCross-Over Studiesen
dc.subject.meshDiagnostic Tests, Routineen
dc.subject.meshDrug Therapy, Combinationen
dc.subject.meshFeveren
dc.subject.meshHumansen
dc.subject.meshMalaria, Falciparumen
dc.subject.meshOdds Ratioen
dc.subject.meshPrescriptionsen
dc.subject.meshTanzaniaen
dc.subject.meshTreatment Outcomeen
dc.titleInfluence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation studyen
dc.typeArticleen
dc.contributor.departmentMalaria Control Programme, Ministry of Health and Social Welfare, Zanzibar, Tanzania; Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of International Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm; Medecins Sans Frontieres, Dar es Salaam, Tanzania; World Health Organization (WHO) Country Office, Dar es Salaam, Tanzania; Nordic School of Public Health, Gothenburg, Sweden; Global Malaria Programme, WHO, Geneva, Switzerlanden
dc.identifier.journalPLoS Medicineen
refterms.dateFOA2019-03-04T08:23:39Z
html.description.abstractBACKGROUND: The use of rapid diagnostic tests (RDTs) for Plasmodium falciparum malaria is being suggested to improve diagnostic efficiency in peripheral health care settings in Africa. Such improved diagnostics are critical to minimize overuse and thereby delay development of resistance to artemisinin-based combination therapies (ACTs). Our objective was to study the influence of RDT-aided malaria diagnosis on drug prescriptions, health outcomes, and costs in primary health care settings. METHODS AND FINDINGS: We conducted a cross-over validation clinical trial in four primary health care units in Zanzibar. Patients of all ages with reported fever in the previous 48 hours were eligible and allocated alternate weeks to RDT-aided malaria diagnosis or symptom-based clinical diagnosis (CD) alone. Follow-up was 14 days. ACT was to be prescribed to patients diagnosed with malaria in both groups. Statistical analyses with multilevel modelling were performed. A total of 1,887 patients were enrolled February through August 2005. RDT was associated with lower prescription rates of antimalarial treatment than CD alone, 361/1005 (36%) compared with 752/882 (85%) (odds ratio [OR] 0.04, 95% confidence interval [CI] 0.03-0.05, p<0.001). Prescriptions of antibiotics were higher after RDT than CD alone, i.e., 372/1005 (37%) and 235/882 (27%) (OR 1.8, 95%CI 1.5-2.2, p<0.001), respectively. Reattendance due to perceived unsuccessful clinical cure was lower after RDT 25/1005 (2.5%), than CD alone 43/882 (4.9%) (OR 0.5, 95% CI 0.3-0.9, p = 0.005). Total average cost per patient was similar: USD 2.47 and 2.37 after RDT and CD alone, respectively. CONCLUSIONS: RDTs resulted in improved adequate treatment and health outcomes without increased cost per patient. RDTs may represent a tool for improved management of patients with fever in peripheral health care settings. TRIAL REGISTRATION: (Clinicaltrials.gov) NCT00549003.


Files in this item

Thumbnail
Name:
090428_Msellem_malaria-RDTs-Za ...
Size:
208.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record